Skip to content

An Alzheimer's breakthrough?

Unexplainable

28m
Transcript

Original podcast

Where to listen

Summary

Written by a model from the transcript; not yet reviewed.

Alzheimer's research has long been marked by dead ends, controversy, and a lack of effective treatments, but recent developments offer genuine grounds for cautious optimism. Vox senior correspondent Dylan Scott joins the show to discuss what has changed over the past five years, from newly approved medications like lecanumab and donanumab that slow cognitive decline to intriguing correlations with common interventions like the shingles vaccine. They also examine dramatic and unverified experimental surgeries from China that claim to reverse symptoms, exploring both the scientific intrigue and the desperate context of a disease that strips away personal identity.

The discussion highlights the immense emotional and financial toll of Alzheimer's, which currently affects 57 million people worldwide and is projected to triple by 2050. While the new drugs only slow down the disease rather than cure it, and many promising candidates will likely fail, researchers now share a more robust understanding of the disease as a multifaceted condition. Ultimately, the incremental progress represents a major shift from the dark era of a few years ago, providing a stronger foundation for future scientific breakthroughs.

  • Cardiovascular health and lifestyle choices early in life may help delay or prevent the onset of Alzheimer's disease. 13:22
  • Receiving the shingles vaccine appears to be associated with a reduced risk of developing Alzheimer's disease later in life. 14:51
  • Two approved drugs, lecanumab and donanumab, target amyloid plaques to successfully slow down cognitive decline in patients. 10:32
  • Global dementia cases stand at 57 million and are expected to triple by the year 2050. 21:11

Chapters

  1. 0:01
    Podcast Introduction and Sponsorships

    Hosts open the episode, mention TikTok sponsorship, and preview the topic of Alzheimer’s breakthroughs.

  2. 1:23
    Unusual Alzheimer’s Recovery Videos from China

    Hosts discuss viral videos of elderly patients regaining speech and memory after experimental surgery.

  3. 2:33
    History of Alzheimer’s Research and Recent Breakthroughs

    Guest Dylan Scott recounts the long stagnation in Alzheimer’s treatments and the recent shift toward promising therapies.

  4. 4:24
    Mechanisms of Alzheimer’s Disease Explained

    Scott explains beta‑amyloid plaques, tau tangles, and inflammation as key drivers of cognitive decline.

  5. 10:16
    Preventive Strategies and New Drug Approvals

    Discussion of lifestyle factors, shingles vaccine link, and the FDA‑approved drugs lecanumab and donanemab.

  6. 11:37
    Experimental Brain‑Drain Surgery and Its Controversy

    Hosts examine the Chinese surgery videos, scientific skepticism, and the need for Western replication studies.

  7. 15:44
    Patient Perspectives and the Reality of Hope

    The conversation turns to caregivers’ experiences, the emotional toll, and the balance between optimism and caution.

  8. 28:37
    Future Outlook and Closing Remarks

    Scott summarizes the cautious optimism in Alzheimer’s research and the hosts wrap up the episode.

Highlights

  • TikTok 0:01–0:45
  • Quince 16:02–17:22
  • TikTok 17:27–18:37
  • Michelob Ultra 18:44–19:49

About this episode

The past few months have been full of Alzheimer's optimism: new ideas that could prevent the disease from taking hold, medications that seem to slow it down, and an experimental surgery that might even be able to reverse its progression. It's a lot of hype. Should we believe it? Guest: ⁠⁠Dylan Scott⁠⁠, senior correspondent at Vox To watch this episode on video, find us on ⁠⁠⁠Netflix⁠⁠⁠! For show transcripts, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠vox.com/unxtranscripts ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠For more, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠vox.com/unexplainable ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠And please email us! ⁠⁠⁠⁠unexplainable@vox.com⁠⁠⁠⁠We read every email. Support Unexplainable (and get ad-free episodes) by becoming a Vox Member today: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠vox.com/members Learn more about your ad choices. Visit podcastchoices.com/adchoices

Transcript

0:00
28:03

4,885 words · 8 speakers

Topics

  • shingles vaccine
  • FDA
  • Vox
  • China
  • United States
  • Europe
  • Netflix
  • Vox Media
  • lecanumab
  • donanumab

Page updated · transcript and summary are machine-generated